Juventas Cell Therapy closes a $63M funding round as it eyes a big push for blood cancer hopeful
Juventas Cell Therapy closes a $63M funding round as it [...]
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th [...]
Egle Therapeutics nabs $46M as it looks to push into the clinic with next-gen Tregs platform
Egle Therapeutics nabs $46M as it looks to push into [...]
Metacrine shares halved as NASH program nixed on mixed bag data and early safety issue
Metacrine shares halved as NASH program nixed on mixed bag [...]
Could cancer drugs address a hard-to-treat lung disease? Researchers say 2 look promising
Could cancer drugs address a hard-to-treat lung disease? Researchers say [...]
Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and a backer with intimate knowledge of its rival
Ventyx nabs a $152M upsized IPO to challenge BMS’ Zeposia—and [...]
VCs back Leucid to trial CAR-T twist in ovarian cancer patients
VCs back Leucid to trial CAR-T twist in ovarian cancer [...]
Menarini, chased by 3 Big Pharmas, records win in breast cancer phase 3, plots path to FDA
Menarini, chased by 3 Big Pharmas, records win in breast [...]
FDA slaps clinical hold on AstraZeneca cancer drug amid heart safety scare in combo test
FDA slaps clinical hold on AstraZeneca cancer drug amid heart [...]
Chase, after selling last biotech to Allergan, gets cash to start pivotal trials in depression, Parkinson’s
Chase, after selling last biotech to Allergan, gets cash to [...]